Treatable Sites - Hyperthermia Cancer Institute Los Angeles

Hyperthermia has been shown to clinically improve outcomes in many cancer types, without significant or lasting side effects.

BH Thermal Medicine Hyperthermia Outcomes

In an international clinical study conducted in Denmark, the Netherlands and Norway involving 128 patients with recurrent or metastatic malignant melanoma, patients who received hyperthermia therapy along with radiation had a complete response rate for recurrent malignant melanoma lesions of 62% compared to 35% for those who received radiation treatments alone, and the local relapse-free survival rate at 5 years was 46% for those who received both hyperthermia and radiation and 28% for those who received radiation alone. (International Journal of Hyperthermia, Vol., 12, No. 1, 3-20.)